Nanda received his PhD from North Carolina State University and completed his multiple post-doctoral trainings at the National Institutes of Health. Nanda has over 15 years of experience supporting research with pharma, biotech, academia and CROs. He is trained in clinical research, clinical biosafety, and review of clinical trials in gene therapy and inspection of clinical sites. He has managed large research teams, IRB, IACUC, IBC, EHS, well versed in FDA, GMOs, risk management, drug discovery process and GxP. He has worked with thought leaders, is well published and a panel speaker at conferences and served on grant review panels.